Decreased receptor-interacting protein kinase 3 (RIPK3) expression was found to be correlated with increased MDSC number and activity in colorectal and hepatocellular carcinoma, likely mediated by the NF-κB/COX-2/PGE2 axis (31, 78). The gene discussed is RIPK3; the disease is hepatocellular carcinoma.